Adverse event due to a likely interaction between sodium aescinate and ginkgo biloba extract: a case report

Abstract

Close monitoring and the prompt discontinuation of drugs that have high protein-binding capacity and hepatic metabolism are necessary to avoid drug-drug interactions in patients who are treated with sodium aescinate.